Download presentation
Presentation is loading. Please wait.
1
F.Ahmadbadi Child neurologist ARUMS
Pku sCREENING F.Ahmadbadi Child neurologist ARUMS
2
Objectives Epidemiology of PKU in Iran and world Definitions and types
Biochemical view Clinical Manifestations Diagnosis Screening Treatment
3
Epidemiology & Genetic
Prevalence:1/6000-1/10000 Brazil, china,Lativa:1/20000 AR transmission F=M In a study in Shiraz 1/4700 2-3% of causes of MR s
4
Ph A level more than 6 and Tyrosine low than 5
Definition: Ph A level more than 6 and Tyrosine low than 5 Types of PKU Classic Malignant(2% of cases) Transient phenylalaninemia
5
Phenylketonuria Phenylalanine Tyrosine Phenyl ketones PAH THB
6
BH4 is necessary for: Hydroxylation
Tryptophan Serotonin Tyrosine Dopamine Hydroxylation
7
Clinical manifestation
Normal at birth Severe MR(IQ<30) Blound appearance Odor Microcephalia Seborroic dermatitis Dominant maxilla
8
Diagnosis Ferric chloride test(urin phenyl ketones)
Guthrie test Screening test MS/MS Phenylalanin>6mg/dlit(360 mic M) Diagnostic test Thyrosin (low) Phenylalanine hydroxylase gene probe
9
(Filter paper or Serum) Under observe till 1 week
PhA Level <4mg/dl Report 4≤mg/dl Re check (Filter paper or Serum) HPLC <4mg/dl Report Screening For PKU In 3rd- 5th day of life Under observe 6mo-1 year And then Challenge test >4mg/dlit 4-10 mg/dlit >10 mg/dlit Under observe till 1 week & PhA Recheck Diet & Treatment 4-7 mg/dlit 7≤ mg/dlit
10
Specimen Collection
12
False Negative Technical errors Method Humidity Hemodialyse
First days of life(1-2) The false-negative rates ranged from 2% to 31% for the first day of life, but decreased to 0.6% to 2% on the second day and to 0.3% by the third day Technical errors Method Humidity Hemodialyse Exchange Transfusion NPO
13
False Positive In certain situations and population conditions, the ratio of false positives to true positives is as high as 32 to 1.8 Buffy coat in sample Hemolysis Prematurity Liver diseases Tyrosinemia Renal diseases TMP-SMX Maternal PKU
14
Treatment Low phenylalanin Regimen (Phenylalanin2-6mg/dlit)
Treatment must start in first 7-10 days of life. It must be continued till yrs old or even lifelong. In malignant PKU, Neurotransmitters are needed. (BH4-Dopamin_serotonine) Maternal hyperphenylallanenimiaMR-Microcephallia-CHD
15
Lofenolac Comida(A,B,C) Xp-Analog Xp-Maxamaid Xp-Maxamum
16
Some drugs such as Farmentin have aspartame and thus not suitable for PKU cases
Diet drinks (carbonated) have Aspartame.
17
With the Best Wishes
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.